Table 1.

Baseline characteristics of participants who did not versus those who developed MCI.

Characteristic*	Did not develop MCI N=456	Developed MCI N=305	P Value
Age	77.9, 7.21	81.0, 6.30	<0.001
Gender (% Female)	76.7%	74.4%	0.489
Race (% White, non-Hispanic)	89.6%	92.8%	0.142
Education	14.5, 2.91	14.8, 3.25	0.247
Global cognitive function	0.42, 0.38	0.14, 0.40	<0.001
Physical frailty	−0.19, 0.54	0.00, 0.55	>0.001
Grip strength	−51.43, 19.05	−47.99, 18.43	0.007
Timed walk	2.59, 1.37	3.07, 1.46	<0.001
BMI	−27.87, 5,43	−27.27, 4.84	0.165
Fatigue	1.14, 0.28	1.18, 0.33	0.153
Depressive symptoms	0.85, 1.39	0.92, 1.36	0.319
Vascular risk factors	1.16, 0.85	1.10, 0.79	0.430
Hypertension (% yes)	59%	42%	0.878
Smoking (% yes)	41%	39%	0.692
Diabetes (% yes)	15%	11%	0.104
Vascular diseases	0.32, 0.62	0.26, 0.51	0.539
Claudication (% yes)	5%	6%	0.613
Congestive heart failure (% yes)	5%	5%	0.920
Heart attack (% yes)	12%	36%	0.290
Stroke (% yes)	9%	7%	0.400
Katz Disability	0.10, 0.48	0.19, 0.63	0.005
Katz=1 or more (%)	6%	11%	0.005
IADL Disability	0.60, 0.96	0.99, 1.30	<0.001
IADL=1 or more (%)	12%	25%	<0.001
Income	6.80 (2.52)	6.40 (2.57)	0.061

^*Mean values and standard deviations are presented unless otherwise noted and statistical significance is based on t-tests, Wilcoxon rank sum test or Chi-Square tests, as appropriate.